What is the recommended dosage and treatment duration for nystatin (antifungal medication) swish and swallow for oral thrush?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nystatin Swish and Swallow for Oral Thrush

For mild oral thrush, nystatin suspension should be dosed at 4-6 mL (400,000-600,000 units) four times daily for 7-14 days, with the medication swished in the mouth as long as possible before swallowing, though fluconazole is preferred for moderate-to-severe disease due to superior efficacy. 1, 2

Dosing and Administration

Standard Adult Dosing

  • Nystatin suspension: 4-6 mL (400,000-600,000 units) four times daily 3, 1, 2
  • Alternative: Nystatin pastilles 1-2 tablets (200,000 units each) four times daily 1
  • Treatment duration: 7-14 days minimum 3, 1, 2

Proper Swish and Swallow Technique

  • Swish the suspension thoroughly throughout the mouth for as long as possible (at least 2 minutes) to ensure contact with all affected areas 1
  • Swallow the medication after swishing rather than spitting it out to treat potential esophageal involvement 1
  • Place one-half of the dose in each side of the mouth 2
  • Continue treatment for at least 48 hours after symptoms resolve and cultures confirm eradication of Candida 2

Treatment Algorithm by Disease Severity

Mild Oral Thrush

  • First-line options include clotrimazole troches (10 mg 5 times daily) or nystatin suspension as described above 4
  • Miconazole mucoadhesive buccal tablet (50 mg once daily) is an alternative 4

Moderate-to-Severe Oral Thrush

  • Oral fluconazole 100-200 mg daily for 7-14 days is first-line therapy and superior to nystatin 3, 4, 1
  • Nystatin is relegated to mild disease due to lower efficacy compared to systemic azoles 3

Important Clinical Caveats

Limitations of Nystatin

  • Topical agents like nystatin have suboptimal tolerability (bitter taste, gastrointestinal side effects, frequent dosing) and lower efficacy compared to fluconazole 3
  • Research demonstrates nystatin clinical cure rates of only 32-54% compared to 100% with fluconazole in infants 5, 6
  • Nystatin should not be first-line for moderate-to-severe disease or immunocompromised patients 3, 1

Special Populations and Considerations

  • For denture-related candidiasis, denture disinfection must accompany antifungal therapy, with dentures removed at night and cleaned thoroughly 4, 1
  • For HIV-infected patients, antiretroviral therapy is strongly recommended to reduce recurrent infections, and systemic therapy may be more appropriate 4, 1
  • For recurrent oral thrush, fluconazole 100 mg three times weekly is recommended for chronic suppressive therapy 4, 1

Refractory Disease

If symptoms persist despite nystatin treatment:

  • Itraconazole solution 200 mg once daily 3, 4
  • Posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily 3, 4
  • Voriconazole 200 mg twice daily 3, 4
  • Amphotericin B oral suspension 100 mg/mL four times daily 3, 4

Patients Unable to Tolerate Oral Therapy

  • Intravenous fluconazole 400 mg (6 mg/kg) daily 4
  • Intravenous echinocandin (caspofungin, micafungin, or anidulafungin) 3, 4
  • Intravenous amphotericin B deoxycholate 0.3 mg/kg daily as less preferred alternative 3, 4

References

Guideline

Nystatin Treatment for Oral Thrush

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Oral Thrush

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.